Literature DB >> 27901620

Etiology and Clinical Features of Ocular Inflammatory Diseases in a Tertiary Referral Centre in Sydney, Australia.

Sophia L Zagora1,2, Richard Symes1,2, Aaron Yeung1,2, Will Yates1,2, Denis Wakefield3, Peter J McCluskey1,2.   

Abstract

PURPOSE: To report the pattern of uveitis in patients attending a tertiary uveitis service in Sydney, Australia.
METHODS: The charts of patients seen between January 2009 and December 2015 were retrospectively reviewed. Data pertaining to patient demographics, eye examination on presentation, work-up and final diagnoses were collected.
RESULTS: The total number of patients with uveitis seen over this period was 1165. There were 650 males (56%) and 515 females (44%). There were 838 patients aged 17-60 years (72%) and 327 patients aged >60 years (28%). Uveitis was anterior in 735 patients (63%), posterior in 234 patients (20%), pan in 109 patients (9%), and intermediate in 87 patients (8%). The most common associations were HLA-B27+ve (264 patients; 22.8%), sarcoidosis (78 patients; 6.7%) and Fuchs (33 patients; 2.8%), while VZV (51 patients; 4.4%), HSV (49 patients; 4.2%), tuberculosis (49 patients; 4.2%) and toxoplasmosis (48 patients; 4.1%) were the most common infectious causes of uveitis. No identifiable association was found in 389 patients (33.4%). HLA-B27 was more common in the younger age group compared with the older age group (p<0.001, χ2-test), but there was no difference between the age groups for no identifiable cause (p value 0.24) and sarcoidosis (p value 0.08).
CONCLUSIONS: This retrospective case review reveals a broad spectrum of uveitis in a tertiary referral service in Sydney, Australia. It is comparable with other major studies around the world.

Entities:  

Keywords:  Epidemiology; inflammatory eye disease; ocular inflammation; uveitis

Mesh:

Year:  2016        PMID: 27901620     DOI: 10.1080/09273948.2016.1247871

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

Review 1.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

Review 2.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

Review 3.  The microbiome and HLA-B27-associated acute anterior uveitis.

Authors:  James T Rosenbaum; Mark Asquith
Journal:  Nat Rev Rheumatol       Date:  2018-12       Impact factor: 20.543

Review 4.  Noninfectious uveitis in the Asia-Pacific region.

Authors:  Yung-Ray Hsu; Jerry Chien-Chieh Huang; Shih-Hwa Chiou; De-Kuang Hwang; Yong Tao; Toshikatsu Kaburaki; Christopher Seungkyu Lee; Tai-Chi Lin; Chih-Chien Hsu
Journal:  Eye (Lond)       Date:  2018-10-15       Impact factor: 3.775

5.  Classification Criteria for Multifocal Choroiditis With Panuveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

Review 6.  Systemic immunosuppressive therapies for uveitis in developing countries.

Authors:  Hitesh Agrawal; Hien Doan; Brandon Pham; Amit Khosla; Manohar Babu; Peter McCluskey; Quan Dong Nguyen; Virender Sangwan; Subhakar Reddy; Sujata Sawhney; Mudit Tyagi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

7.  Adalimumab in patients with vision-threatening uveitis: real-world clinical experience.

Authors:  Timothy Lee Tang Lee Say; Verlyn Yang; Jacob M Fingret; Sophia Zagora; Richard Symes; Christine Younan; Elisa Eleanor Cornish; Nitin Verma; Anthony Sammel; Denis Wakefield; Deborah Speden; Peter J McCluskey
Journal:  BMJ Open Ophthalmol       Date:  2021-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.